| __timestamp | Perrigo Company plc | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 152500000 | 11768000 |
| Thursday, January 1, 2015 | 187800000 | 15152000 |
| Friday, January 1, 2016 | 184000000 | 19828000 |
| Sunday, January 1, 2017 | 167700000 | 25573000 |
| Monday, January 1, 2018 | 218600000 | 23634000 |
| Tuesday, January 1, 2019 | 187400000 | 38845000 |
| Wednesday, January 1, 2020 | 177700000 | 50523000 |
| Friday, January 1, 2021 | 122000000 | 75463000 |
| Saturday, January 1, 2022 | 123100000 | 105767000 |
| Sunday, January 1, 2023 | 122500000 | 167512000 |
Cracking the code
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Perrigo Company plc and Xenon Pharmaceuticals Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Perrigo's R&D expenses have shown a steady decline, dropping from 15% of their 2014 spending to just 8% in 2023. In contrast, Xenon Pharmaceuticals has ramped up its R&D investment significantly, increasing its spending by over 1,300% during the same period.
This divergence highlights Xenon's aggressive pursuit of innovation, as it seeks to carve out a niche in the competitive pharmaceutical market. Meanwhile, Perrigo's more conservative approach may reflect a strategic focus on other business areas. As the industry continues to evolve, these spending patterns offer a glimpse into the future trajectories of these two companies.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Perrigo Company plc
Analyzing R&D Budgets: Zoetis Inc. vs Perrigo Company plc
Comparing Innovation Spending: GSK plc and Perrigo Company plc
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Perrigo Company plc
Comparing Innovation Spending: Biogen Inc. and Xenon Pharmaceuticals Inc.
Comparing Innovation Spending: Neurocrine Biosciences, Inc. and Perrigo Company plc
Who Prioritizes Innovation? R&D Spending Compared for Jazz Pharmaceuticals plc and Perrigo Company plc
Axsome Therapeutics, Inc. or Xenon Pharmaceuticals Inc.: Who Invests More in Innovation?
Research and Development Investment: Rhythm Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Research and Development Expenses Breakdown: Xenon Pharmaceuticals Inc. vs Catalyst Pharmaceuticals, Inc.
Analyzing R&D Budgets: Xenon Pharmaceuticals Inc. vs Iovance Biotherapeutics, Inc.
Xenon Pharmaceuticals Inc. or Taro Pharmaceutical Industries Ltd.: Who Invests More in Innovation?